Corvus Pharmaceuticals, Inc. (CRVS) ownership: Top institutional holder: ORBIMED ADVISORS LLC ($104.82M). Insider activity: Net Seller (3 buys, 17 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 7165006.00 | $104.82M | 2026-03-31 |
| BlackRock, Inc. | 6160422.00 | $90.13M | 2026-03-31 |
| STATE STREET CORP | 3565992.00 | $52.17M | 2026-03-31 |
| ADAMS STREET PARTNERS LLC | 3275616.00 | $47.92M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3234538.00 | $47.32M | 2026-03-31 |
| Vivo Capital, LLC | 2805816.00 | $41.05M | 2026-03-31 |
| MORGAN STANLEY | 2498825.00 | $36.56M | 2026-03-31 |
| Deep Track Capital, LP | 2491539.00 | $36.45M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Buy | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Buy | null | 2026-05-18 | |
| Buy | null | 2026-05-18 |
Back to CRVS overview · CRVS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.